en
Scientific article
English

Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis

Published inAnnals of the rheumatic diseases, vol. 75, no. 3, p. 532-539
Publication date2016
Abstract

To investigate the impact of smoking on the response to treatment with a first tumour necrosis factor inhibitor (TNFi) in patients with axial spondyloarthritis (axSpA) in a real-life cohort.

Citation (ISO format)
CIUREA, Adrian et al. Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis. In: Annals of the rheumatic diseases, 2016, vol. 75, n° 3, p. 532–539. doi: 10.1136/annrheumdis-2013-205133
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-4967
486views
0downloads

Technical informations

Creation10/09/2015 9:47:00 AM
First validation10/09/2015 9:47:00 AM
Update time03/14/2023 11:53:55 PM
Status update03/14/2023 11:53:54 PM
Last indexation01/16/2024 7:39:24 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack